On April 23, Acting Attorney General Todd Blanche announced a final order reclassifying US Food and Drug Administration (FDA)-approved drug products containing “marijuana” and cannabis products regulated under qualifying state-issued medical marijuana licenses from Schedule I to Schedule III of the Controlled Substances Act (CSA), effective April 28. Critically, adult-use (recreational) cannabis remains in Schedule I.